Cargando...

When is Genomic Testing Cost-Effective? Testing for Lynch Syndrome in Patients with Newly-Diagnosed Colorectal Cancer and Their Relatives

Varying estimates of the cost-effectiveness of genomic testing applications can reflect differences in study questions, settings, methods and assumptions. This review compares recently published cost-effectiveness analyses of testing strategies for Lynch Syndrome (LS) in tumors from patients newly d...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Healthcare (Basel)
Autor principal: Grosse, Scott D.
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2015
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4604059/
https://ncbi.nlm.nih.gov/pubmed/26473097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/healthcare3040860
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!